首页> 外文期刊>Cell death and differentiation >Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells.
【24h】

Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells.

机译:炎性细胞因子对甲状腺上皮细胞中TRAIL介导的细胞凋亡的调节。

获取原文
获取原文并翻译 | 示例
           

摘要

Death receptor-mediated apoptosis has been implicated in target organ destruction in chronic autoimmune thyroiditis. Depending on the circumstances, inflammatory cytokines such as IL-1, TNF and IFNgamma have been shown to contribute to either the induction, progression or inhibition of this disease. Here we demonstrate that the death ligand TRAIL can induce apoptosis in primary, normal, thyroid epithelial cells under physiologically relevant conditions, specifically, treatment with the combination of inflammatory cytokines IL-1beta and TNFalpha. In contrast, IFNgamma is capable of blocking TRAIL-induced apoptosis in these cells. This regulation of TRAIL-mediated apoptosis by inflammatory cytokines appears to be due to alterations of cell surface expression of TRAIL receptor DR5 and not DR4. We also show the in vivo presence of TRAIL and TRAIL receptors DR5 and DcR1 in both normal and inflamed thyroids. Our data suggests TRAIL-mediated apoptosis may contribute to target organ destruction in chronic autoimmune thyroiditis. DOI: 10.1038/sj/cdd/4400965
机译:死亡受体介导的细胞凋亡与慢性自身免疫性甲状腺炎的靶器官破坏有关。视情况而定,炎症细胞因子(例如IL-1,TNF和IFNγ)已显示出对该疾病的诱导,进展或抑制作用。在这里,我们证明了死亡配体TRAIL在生理相关条件下,特别是与炎性细胞因子IL-1beta和TNFalpha结合治疗时,可以诱导原代,正常甲状腺上皮细胞凋亡。相反,IFNgamma能够阻断TRAIL诱导的这些细胞凋亡。炎性细胞因子对TRAIL介导的凋亡的这种调节似乎是由于TRAIL受体DR5而非DR4的细胞表面表达的改变。我们还显示了正常甲状腺和发炎甲状腺中TRAIL和TRAIL受体DR5和DcR1的体内存在。我们的数据表明,TRAIL介导的细胞凋亡可能有助于慢性自身免疫性甲状腺炎中靶器官的破坏。 DOI:10.1038 / sj / cdd / 4400965

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号